Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/2/2026

1. NKE
2. USO
3. SPY
4. ACN
5. NVDA
6. FICO
7. TRU
8. TLT
9. LAES
10. WBD

Go back to Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates
(NASDAQ: ALGS) Delayed: 5.54 +0.04 (0.73%)
Previous Close $5.50    52 Week High $ 
Open $5.58    52 Week Low $ 
Day High $5.72    P/E N/A 
Day Low $5.37    EPS $ 
Volume 28,978       

(NASDAQ: ALGS) Delayed: 5.54 +0.04 (0.73%)
Previous Close $5.50    52 Week High $ 
Open $5.58    52 Week Low $ 
Day High $5.72    P/E N/A 
Day Low $5.37    EPS $ 
Volume 28,978